Metabolic Signatures of Lung Cancer in Biofluids: NMR-Based Metabonomics of Blood Plasma
about
Human plasma metabolomics in age-related macular degeneration (AMD) using nuclear magnetic resonance spectroscopy.Combining NMR and LC/MS Using Backward Variable Elimination: Metabolomics Analysis of Colorectal Cancer, Polyps, and Healthy Controls.Racial disparity in metabolic regulation of cancer.(1)H NMR Metabolomics Study of Metastatic Melanoma in C57BL/6J Mouse Spleen.Metabonomic profiling of serum and urine by (1)H NMR-based spectroscopy discriminates patients with chronic obstructive pulmonary disease and healthy individuals.NMR and LC/MS-based global metabolomics to identify serum biomarkers differentiating hepatocellular carcinoma from liver cirrhosis.Plasma metabolite profiling and chemometric analyses of lung cancer along with three controls through gas chromatography-mass spectrometry.Metabolomics method to comprehensively analyze amino acids in different domainsSystemic Metabolomic Changes in Blood Samples of Lung Cancer Patients Identified by Gas Chromatography Time-of-Flight Mass SpectrometryIdentification of Serum Markers of Esophageal Adenocarcinoma by Global and Targeted Metabolic ProfilingMetabolomic markers of altered nucleotide metabolism in early stage adenocarcinomaTemporal characterization of serum metabolite signatures in lung cancer patients undergoing treatmentSerum metabolomic profiling facilitates the non-invasive identification of metabolic biomarkers associated with the onset and progression of non-small cell lung cancer.Differentiating hepatocellular carcinoma from hepatitis C using metabolite profiling.Plasma metabolomic analysis of human hepatocellular carcinoma: Diagnostic and therapeutic studyRecent advances in metabolomics in oncology.An omics strategy for discovering pulmonary biomarkers potentially relevant to the evaluation of tobacco products.NMR-based metabolomics coupled with pattern recognition methods in biomarker discovery and disease diagnosis.Metabolic profiling of biofluids: potential in lung cancer screening and diagnosis.Metabolic phenotyping of human plasma by 1 H-NMR at high and medium magnetic field strengths: a case study for lung cancer.Integrated Metabolomics and Proteomics Highlight Altered Nicotinamide- and Polyamine Pathways in Lung Adenocarcinoma.Serum metabolomic analysis of human upper urinary tract urothelial carcinoma.CE-MS based on moving reaction boundary method for urinary metabolomic analysis of gastric cancer patients.Molecular signatures of lung cancer: defining new diagnostic and therapeutic paradigms.NMR HRMAS spectroscopy of lung biopsy samples: Comparison study between human, pig, rat, and mouse metabolomics.Exploratory investigation of plasma metabolomics in human lung adenocarcinoma.Metabolic changes of different high-resolution computed tomography phenotypes of COPD after budesonide-formoterol treatment.Serum Metabolic Profile Alteration Reveals Response to Platinum-Based Combination Chemotherapy for Lung Cancer: Sensitive Patients Distinguished from Insensitive ones.Optimized Phenotypic Biomarker Discovery and Confounder Elimination via Covariate-Adjusted Projection to Latent Structures from Metabolic Spectroscopy Data.Metabolic phenotyping of human blood plasma: a powerful tool to discriminate between cancer types?Analysis of volatile organic compounds in pleural effusions by headspace solid-phase microextraction coupled with cryotrap gas chromatography and mass spectrometry.High-throughput and high-sensitivity quantitative analysis of serum unsaturated fatty acids by chip-based nanoelectrospray ionization-Fourier transform ion cyclotron resonance mass spectrometry: early stage diagnostic biomarkers of pancreatic cancer1H NMR metabolic profiling of gastric cancer patients with lymph node metastasis.SERUM metabolomics of acute lymphoblastic leukaemia and acute myeloid leukaemia for probing biomarker molecules.In vivo efficacy of melanoma internal radionuclide therapy with a 131I-labelled melanin-targeting heteroarylcarboxamide molecule.Serum proton NMR metabolomics analysis of human lung cancer following microwave ablation.NMR-based metabolomics in human disease diagnosis: applications, limitations, and recommendationsNuclear Magnetic Resonance technique in tumor metabolismThe plasma glutamate concentration as a complementary tool to differentiate benign PET-positive lung lesions from lung cancerMetabolome-based biomarkers: their potential role in the early detection of lung cancer
P2860
Q33703808-B618BAC1-EB06-4880-80AE-640A91E662D9Q33745104-EDFEBE7E-219E-442A-9E45-2ADC78AA1CCAQ33906704-9843BCF4-0674-4C1D-8581-4CEC7E4C7FA8Q34453064-895561B6-88F7-4F0B-968E-14B0A581D511Q34766684-EA97DA2D-9233-45B4-880E-941049D89EB0Q35079419-5D49BABF-373F-4C3F-8154-0A8F9CDB0E6CQ35119518-C3E48756-F3CC-4C79-9231-3201CEB4E46CQ35235756-F365A469-F8BF-4B66-B39A-CA5975F90851Q35829888-3458BA49-0EAC-4CDB-A386-552B565A4AD4Q36130496-7B8CC2EB-1D23-44DD-9023-2D271C29629AQ36201742-D4EFEFE0-8CDD-4306-80C9-A341A43E5B76Q36761890-FDC12E10-82BD-40C3-A133-CD1236A1F6C6Q37022332-05CCD013-9A3C-48DF-A970-993504F0FAE2Q37512658-86171B01-0B7D-4C62-898D-FB1A63033583Q37565131-11EF7B83-EDE3-4397-B625-EB0EBD0BCFC8Q37990967-A5ACACFB-3F61-46AD-9721-AB25FE1105ABQ38066244-BB9B7FCD-E08F-49D0-96BE-C04C72927F6CQ38119451-1B7EB65A-62C9-4040-94A1-642A5AB483AFQ38142255-E87D3A2E-05B3-4380-8878-0F45266AD1EAQ39035679-C928E994-64BD-4938-AE95-2E9657C3D542Q39042259-27C89753-4659-4A7F-A52A-C58AC5726850Q41009514-27CA231C-98ED-450F-B577-9412BD66EDEBQ43593965-F4EEFCE6-204B-4DEA-8BA2-5A61EDACAB92Q44582343-69B9E652-401F-482F-829F-C0943372D4EDQ45143207-D53621B2-C370-441C-BF83-631DD78FE3B6Q45753612-2B1171A0-3B1E-429B-8344-8FB05BCA5A0DQ47103106-FC9350AE-77E5-494E-99A9-38E38382023CQ47155641-D153744A-A5D2-4BFD-8034-954A283E71CEQ49849747-B0D1FEC8-E65F-40D0-9938-B4E4776DB63EQ50969598-A34292F3-18C1-4036-B70B-F8860446C76AQ51339787-3C6674FE-01A3-4708-8DC9-E3357C5DAEF7Q51521398-61BDF39D-2EA1-4F5F-B6D2-3928C5C24292Q52655257-00B84850-EAB2-4FB1-B1C7-452401671A1CQ53086161-BA06F80E-DD34-4C06-8527-4EA9BC4F6470Q53120428-48E6449C-62DB-4203-B6D4-C4BCCC550931Q55091863-F317C962-08E0-418C-BAB4-8088E9A5B7CCQ57016043-D4372BB9-E892-4D7D-81DD-D64F71086DCDQ57095244-7F7DFF93-3FEA-4970-86F3-C07799AC855DQ58768473-2E20C3FF-FF7E-466B-995F-ED701CC9D134Q59129088-5CADC3FF-5DAC-4F1F-9DA3-4D67344A9912
P2860
Metabolic Signatures of Lung Cancer in Biofluids: NMR-Based Metabonomics of Blood Plasma
description
im September 2011 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 05 August 2011
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована у вересні 2011
@uk
name
Metabolic Signatures of Lung Cancer in Biofluids: NMR-Based Metabonomics of Blood Plasma
@en
Metabolic Signatures of Lung Cancer in Biofluids: NMR-Based Metabonomics of Blood Plasma
@nl
type
label
Metabolic Signatures of Lung Cancer in Biofluids: NMR-Based Metabonomics of Blood Plasma
@en
Metabolic Signatures of Lung Cancer in Biofluids: NMR-Based Metabonomics of Blood Plasma
@nl
prefLabel
Metabolic Signatures of Lung Cancer in Biofluids: NMR-Based Metabonomics of Blood Plasma
@en
Metabolic Signatures of Lung Cancer in Biofluids: NMR-Based Metabonomics of Blood Plasma
@nl
P2093
P50
P356
P1476
Metabolic signatures of lung cancer in biofluids: NMR-based metabonomics of blood plasma
@en
P2093
João Bernardo
Vitor Sousa
P304
P356
10.1021/PR200550P
P50
P577
2011-08-05T00:00:00Z